Artemis Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-145,269
Closed -$14.4M 267
2019
Q3
$14.4M Buy
145,269
+3,395
+2% +$323K 0.2% 139
2019
Q2
$13.1M Sell
141,874
-20,792
-13% -$1.97M 0.15% 165
2019
Q1
$15.4M Sell
162,666
-15,267
-9% -$1.34M 0.18% 154
2018
Q4
$11.4M Buy
177,933
+46,607
+35% +$3.44M 0.15% 163
2018
Q3
$11.8M Buy
131,326
+130,025
+9,994% +$11.5M 0.13% 176
2018
Q2
$103K Hold
1,301
﹤0.01% 231
2018
Q1
$116K Hold
1,301
﹤0.01% 222
2017
Q4
$136K Sell
1,301
-149,857
-99% -$16.9M ﹤0.01% 218
2017
Q3
$22M Buy
151,158
+30,667
+25% +$4.18M 0.45% 62
2017
Q2
$15.6M Buy
+120,491
New +$14.8M 0.38% 66
2015
Q2
Sell
-49,693
Closed -$5.73M 307
2015
Q1
$5.73M Buy
49,693
+45,737
+1,156% +$5.47M 0.23% 108
2014
Q4
$443K Buy
+3,956
New +$417K 0.02% 220

Other funds holding CELG

Artemis Investment Management's CELG Position: Q4 2019 in Review

Artemis Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 145,269 shares — an estimated $14.4M sold.

Artemis Investment Management first reported a position in CELG in Q4 2014 and held it in 12 quarters. The position peaked at $22M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Artemis Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Artemis Investment Management sold 145,269 Celgene Corp shares in Q4 2019, an estimated $14.4M.
  • Artemis Investment Management first reported a position in Celgene Corp in Q4 2014 and held it in 12 quarters.
  • Artemis Investment Management's Celgene Corp position peaked at $22M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Artemis Investment Management's 13F filing for Q4 2019, filed 14 Jan 2020.